DNM2 and pancreatic ductal adenocarcinoma: Spots specifically reacting with auto-antibodies from the sera of pancreatic ductal adenocarcinoma patients, which were analyzed by mass spectrometry, corresponded to metabolic enzymes or cytoskeletal proteins which proved to be specific targets of the humoral response to pancreatic ductal adenocarcinoma.